Dec 08, 2022 / 04:30PM GMT
Robert Kraft - SNN Incorporated - Moderator
Welcome everyone to the Planet MicroCap Showcase virtual. I'm your host, Robert Kraft. Now I'd like to introduce our next presenter. It is Mina Sooch, Founder and CEO of Ocuphire Pharma. It's a publicly-traded company. The symbol is OCUP on NASDAQ. Mina, take it away.
Mina Sooch - Ocuphire Pharma, Inc. - Vice Chair of the Board & CEO
Thank you, Bob, for inviting Ocuphire to share their story with your audience and investors. Ocuphire Pharma, we are a publicly traded company on the NASDAQ, and so I will be making forward-looking statements and we guide you to our SEC filings for our risk factors.
Who is Ocuphire? It's a 4.5-year old company that I founded here in Michigan, where our goal was to bring underappreciated and derisked assets into Ocuphire, and we chose the ophthalmology area to do so. So we actually have two drug candidates. We have an oral tablet APX3330 for the back of the eye. And we have a product Nyxol for the front of the eye.
Across these two products, we have over four
Ocuphire Pharma Inc at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript
Dec 08, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers